SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-101850
Filing Date
2021-08-09
Accepted
2021-08-09 08:46:06
Documents
49
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clrb-20210630x10q.htm   iXBRL 10-Q 1006880
2 EXHIBIT 31.1 clrb-20210630xex31d1.htm EX-31.1 12622
3 EXHIBIT 31.2 clrb-20210630xex31d2.htm EX-31.2 12593
4 EXHIBIT 32.1 clrb-20210630xex32d1.htm EX-32.1 8262
  Complete submission text file 0001104659-21-101850.txt   4146564

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA clrb-20210630.xsd EX-101.SCH 31805
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clrb-20210630_cal.xml EX-101.CAL 27442
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clrb-20210630_def.xml EX-101.DEF 139626
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20210630_lab.xml EX-101.LAB 273181
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20210630_pre.xml EX-101.PRE 235427
10 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20210630x10q_htm.xml XML 624392
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 211154791
SIC: 2834 Pharmaceutical Preparations